Bion

1.	Clark, G: 1 article (01/2004)
2.	Loeb, G: 1 article (01/2004)
3.	Haberman, P: 1 article (01/2004)
4.	Tran, W: 1 article (01/2004)
5.	R Richmond, F: 1 article (01/2004)
6.	Ahmed, R: 1 article (01/2004)

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 03/01/2002 - "PURPOSE: An experimental hematuria model was designed to determine whether the bladder tumor antigen (BTA) stat test (Bion Diagnostics, Redmond, Washington) is influenced by microscopic or macroscopic hematuria. " 01/01/2002 - "PURPOSE: We determine the sensitivity and specificity of 3 bladder tumor markers in urine, including NMP22 assay (Matritech, Newton, Massachusetts), BTA stat test (Bion Diagnostic Sciences, Inc., Redmond, Washington) and UBC antigen (IDL Biotech, Sollentuna, Sweden), and bladder wash cytology for new and recurrent bladder cancer. " 06/01/2000 - "OBJECTIVE: To determine, in patients newly diagnosed with bladder cancer, whether p53, epidermal growth factor receptor (EGFR), microvessel density (MVD), urinary bladder tumour antigen (BTA TRAKtrade mark, Bion Diagnostic Sciences, Redmond, WA) and cytology were predictive of clinical stage, evaluated as a function of the clinical stage obtained at transurethral resection of the bladder tumour with and without the addition of clinical grade, a known strong predictor of clinical stage. " 09/01/2004 - "In this study we compared the efficacy of the hyaluronic acid (HA)-hyaluronidase (HAase), BTA-Stat (Bard/Bion Diagnostics, Redmond, Washington), Hemastix (Bayer Corp., Elkhart, Indiana) (hematuria detection) and UBC-Rapid (IDL Biotech, Borlänger, Sweden) tests, and cytology to detect bladder cancer. " 08/01/2001 - "PURPOSE: We compared overall sensitivity and specificity of the urinary bladder cancer antigen enzyme-linked immunosorbent assay (UBC, IDL Biotech, Sollentuna, Sweden), BTA stat test (Bion Diagnostic Sciences, Inc., Redmond, Washington) and NMP22 test kit (Matritech, Newton, Massachusetts), and the differential sensitivity regarding the histological pattern of tumors. " Order ALL the reference details at left...
2.	Hematuria 03/01/2002 - "PURPOSE: An experimental hematuria model was designed to determine whether the bladder tumor antigen (BTA) stat test (Bion Diagnostics, Redmond, Washington) is influenced by microscopic or macroscopic hematuria. " 11/01/2002 - "We also evaluated and compared the sensitivity of bladder wash cytology, NMP22 (Matritech, Newton, Massachusetts), BTA Stat (Bion Diagnostic Sciences, Redmond, Washington) and UBC antigen (IDL Biotech, Sollentona, Sweden) with hematuria dipsticks and flow cytometry for determining the size of erythrocytes in urine. " 09/01/2004 - "In this study we compared the efficacy of the hyaluronic acid (HA)-hyaluronidase (HAase), BTA-Stat (Bard/Bion Diagnostics, Redmond, Washington), Hemastix (Bayer Corp., Elkhart, Indiana) (hematuria detection) and UBC-Rapid (IDL Biotech, Borlänger, Sweden) tests, and cytology to detect bladder cancer. " Order ALL the reference details at left...
3.	Headache (Headaches) 02/01/2009 - "Treatment of hemicrania continua by occipital nerve stimulation with a bion device." 11/01/2008 - "METHODS: Six patients aged 18 years or older who were diagnosed with HC had a suboccipital bion device implanted ipsilateral to their headache and received continuous unilateral ONS. " 11/01/2008 - "Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study." 01/01/2004 - "The bion is currently in clinical trials for the treatment of urinary urge incontinence and headaches. " Order ALL the reference details at left...
4.	Urge Urinary Incontinence (Urge Incontinence) 01/01/2004 - "The bion is currently in clinical trials for the treatment of urinary urge incontinence and headaches. " 01/01/2004 - "The bion, through direct electrical stimulation of excitable tissues, is intended to treat numerous disorders including urinary urge incontinence, fecal incontinence, chronic headaches, peripheral pain, angina and obstructive sleep apnea. " Order ALL the reference details at left...
5.	Transitional Cell Carcinoma 11/01/2002 - "In 1 trial we compared the sensitivity of the FISH assay to the BTA Stat test (Bion Scientific, Redmond, Washington) and voided cytology in the detection of transitional cell carcinoma. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Hyaluronoglucosaminidase (Hyaluronidase)
2.	Hyaluronic Acid (Hyaluronan)
3.	Antigens
4.	nuclear matrix protein 22
5.	UBC antigen
6.	Epidermal Growth Factor Receptor (EGF Receptor)
7.	Ions

Best Treatments:
Research Summary Report
on Urinary Bladder Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 641 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>